
Will India benefit as China’s Covid-19 lockdowns hit Apple supply chains?
How China’s pandemic restrictions could reshape Apple’s manufacturing footprint.
Read the story ↗Reporting on healthcare, vaccines, public policy and the human cost of the pandemic in India.

How China’s pandemic restrictions could reshape Apple’s manufacturing footprint.
Read the story ↗
Lockdowns disrupted screening, treatment and support for people affected by leprosy.
Read the story ↗The vaccine inequalities built into the EU’s travel certificate.
Read the story ↗
Children left without parents during the pandemic.
Read the story ↗
The global consequences of unequal access to vaccines.
Read the story ↗
The rise in mucormycosis infections during the second wave.
Read the story ↗
Workers, families and travellers caught by pandemic restrictions.
Read the story ↗
An examination of the pandemic response.
Read the story ↗
The technology behind India’s vaccination effort.
Read the story ↗
Why people’s vaccine celebrations matter.
Read the story ↗
Maternal and newborn care during lockdowns.
Read the story ↗
A contribution to NPR’s global report on community responses.
Read the story ↗
A contribution to NPR’s global remembrance of lives lost to COVID-19.
Read the story ↗
Quarantine surveillance and concerns about civil liberties.
Read the story ↗